We’re proud to share our results for 2025
Click here for the Online reportMeet us at DCAT week
23-26 March 2026, New York city, Benjamin Suite 2601
Schedule a meeting with our teamCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide strengthens financing structure through expansion of existing credit facility
19 Mar 2026 - Baar, 19 March 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the strengthening of its financing structure through the expansion of its existing credit facility. PolyPeptide has expanded its existing […]
Read morePolyPeptide publishes invitation to the annual General Meeting 2026
17 Mar 2026 - Baar, 17 March 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, published today the invitation to the fifth […]
Read more